Intellipharmaceutics International Inc. Announces Stock Option Grant
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company...
Pharmaceutical
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
Revenues increased 7% compared to quarter from prior year and 15% from prior quarterImprovement in gross margin for quarter of...
Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product
News of the Successful Trial Comes Amid an Oversubscribed Investor Round and Preparation for Series A Financing RoundRALEIGH, NC /...
GE HealthCare and MedQuest Associates Collaborate to Provide Innovative Medical Device Technology and Digital Tools for Outpatient Imaging Centers
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MedQuest Associates (MedQuest),...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024
Financials for Third Quarter Fiscal Year 2024 Ended December 31, 2023 will be released on February 14, 2024NORTHVALE, NJ /...
Dr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Jones Healthcare Group’s Qube Pro Wins Prestigious PAC Global Awards
Innovation and Sustainability Lead to Double Award Win for Qube Pro at PAC GlobalLondon, Ontario--(Newsfile Corp. - February 8, 2024)...
Veru Reports Fiscal 2024 First Quarter Financial Highlights
—Company receives FDA IND clearance for the development of enobosarm in combination with GLP-1 drugs for potentially higher quality weight...
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
VANCOUVER, British Columbia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse...
Medexus Announces Fiscal Q3 2024 Results
Fiscal Q3 2024 revenue of $25.2 million, Operating income of $1.6 million, and Adjusted EBITDA* of $3.2 millionManagement to host...
New England Journal of Medicine Publishes Efficacy and Safety Data of Targeted Oral Peptide JNJ-2113 in a Phase 2b Moderate-To-Severe Plaque Psoriasis Study
JNJ-2113 achieved all primary and secondary endpoints in the Phase 2b clinical trial FRONTIER 1, including PASI 100 and IGA...
Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
DENVER, CO / ACCESSWIRE / February 7, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company...
LaVoieHealthScience Welcomes Katie Dodge as Senior Vice President and General Manager
Focus on Agency, Client Excellence, Growth, People and Best PracticesBOSTON & NEW YORK--(BUSINESS WIRE)--LaVoieHealthScience (LHS), an integrated investor and public...
BioNxt Reports Successful Results From ODF Cladribine Toxicity Study
VANCOUVER, BC / ACCESSWIRE / February 7, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to...
TruLab Integration to Florence Streamlines Biospecimen Data Management for Clinical Sites
ATLANTA, GA / ACCESSWIRE / February 7, 2024 / TruLab, a leading provider of sample management solutions, and Florence Healthcare,...
Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering
CAMBRIDGE, MA / ACCESSWIRE / February 7, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that Stéphane Bancel, Chief Executive Officer,...
InfinityRx Appoints Kevin Wong as Chief Technology Officer
Empowering Our Clients With Advanced SolutionsNEW HYDE PARK, NY / ACCESSWIRE / February 7, 2024 / InfinityRx, a copay program...
InfinityRx Appoints Kevin Wong as Chief Technology Officer
Empowering Our Clients With Advanced SolutionsNEW HYDE PARK, NY / ACCESSWIRE / February 7, 2024 / InfinityRx, a copay program...
Two Labs Launches Sunshine Transparency and Aggregate Spend Offering to Provide Transparency Reporting and Compliance Support to the Pharma Industry
COLUMBUS, OH / ACCESSWIRE / February 7, 2024 / Today, Two Labs, an Envision Pharma Company and industry leader in...
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
ALPHARETTA, Ga., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside” or the “Company”) (NASDAQ: CLSD), a biopharmaceutical company revolutionizing...